NCT06831253 Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
| NCT ID | NCT06831253 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Severe Dry Eye Syndromes |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-03-17 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-03-17 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.
Eligibility Criteria
Inclusion Criteria: * Platelet counts, and clotting factors in the standarts * Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist Exclusion Criteria: * Patients with significant fibrosis of the conjunctival portion of the lacrimal gland * Patients with complete stenosis of both lacrimal meatus in the treated eye
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06831253 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Severe Dry Eye Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06831253 currently recruiting?
Yes, NCT06831253 is actively recruiting participants. Contact the research team at causeret.m@chu-nice.fr for enrollment information.
Where is the NCT06831253 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT06831253 clinical trial?
NCT06831253 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 20 participants.